1. Home
  2. SCM vs ETON Comparison

SCM vs ETON Comparison

Compare SCM & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

N/A

Current Price

$9.42

Market Cap

397.8M

Sector

Finance

ML Signal

N/A

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

N/A

Current Price

$16.62

Market Cap

411.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCM
ETON
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.8M
411.9M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
SCM
ETON
Price
$9.42
$16.62
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$13.00
$31.00
AVG Volume (30 Days)
269.5K
298.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
14.03%
N/A
EPS Growth
123.75
N/A
EPS
0.78
N/A
Revenue
N/A
$39,011,000.00
Revenue This Year
N/A
$107.23
Revenue Next Year
N/A
$29.72
P/E Ratio
$12.42
N/A
Revenue Growth
N/A
23.29
52 Week Low
$9.29
$11.09
52 Week High
$15.39
$23.00

Technical Indicators

Market Signals
Indicator
SCM
ETON
Relative Strength Index (RSI) 19.86 48.01
Support Level $9.29 $16.04
Resistance Level $12.40 $17.59
Average True Range (ATR) 0.35 1.03
MACD -0.05 -0.13
Stochastic Oscillator 9.62 7.08

Price Performance

Historical Comparison
SCM
ETON

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: